Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.126x

Based on the latest financial reports, Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a cash flow conversion efficiency ratio of 0.126x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (TL33.37 Million ≈ $747.36K USD) by net assets (TL263.88 Million ≈ $5.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Oncosem Onkolojik Sistemler Sanayi ve Ti to measure how much of total assets are equity-financed.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. - Cash Flow Conversion Efficiency Trend (2020–2023)

This chart illustrates how Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Oncosem Onkolojik Sistemler Sanayi ve Ti earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Alkim Kagit Sanayi ve Ticaret AS IS:ALKA	1.752x
Chialin Precision Industrial Co Ltd TWO:3310	-0.028x
Hwaseung Enterprise Co Ltd KO:241590	0.018x
Financiera Independencia S.A.B. de C.V. SOFOM E.N.R MX:FINDEP	0.097x
Emilia Devel TA:EMDV	0.063x
Dynagas LNG Partners LP NYSE:DLNG	0.054x
Protech Mitra Perkasa Tbk PT JK:OASA	-0.061x
ISC Fresh Water Investment SOCIMI SA MC:YISC	0.120x

Annual Cash Flow Conversion Efficiency for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2023)

The table below shows the annual cash flow conversion efficiency of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2023. For the full company profile with market capitalisation and key ratios, see ONCSM company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2023-12-31	TL231.70 Million ≈ $5.19 Million	TL-38.10 Million ≈ $-853.43K	-0.164x	-169.94%
2022-12-31	TL224.08 Million ≈ $5.02 Million	TL52.69 Million ≈ $1.18 Million	0.235x	-64.14%
2021-12-31	TL78.80 Million ≈ $1.76 Million	TL51.68 Million ≈ $1.16 Million	0.656x	+156.87%
2020-12-31	TL76.02 Million ≈ $1.70 Million	TL19.41 Million ≈ $434.68K	0.255x	--

About Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.

IS:ONCSM Turkey Medical Devices

Market Cap

$132.48 Million

TL5.91 Billion TRY

Market Cap Rank

#18130 Global

#241 in Turkey

Share Price

TL248.00

Change (1 day)

-1.98%

52-Week Range

TL111.60 - TL380.00

All Time High

TL380.00